Differences between centers in functional outcome of patients with ADHD after 1 year from the time of diagnosis
-
Published:2023-10-31
Issue:1
Volume:13
Page:
-
ISSN:2045-2322
-
Container-title:Scientific Reports
-
language:en
-
Short-container-title:Sci Rep
Author:
Cartabia MassimoORCID, Finazzi StefanoORCID, Bonati MaurizioORCID, Bonati MaurizioORCID, Cartabia MassimoORCID, Raschitelli Nicoletta, Zanetti Michele, Conte Stefano, Renzetti Valeria, Stoppa Patrizia, Mauri Valentina, Molteni Massimo, Salandi Antonio, Trabattoni Sara, Effredi Paola, Fazzi Elisa, Filippini Elena, Pedercini Elisabetta, Tiberti Alessandra, Conti Patrizia, Libera Elena Della, Fteita Nadia, Giarelli Maria Teresa, Piccini Giacomo, Viola Luciano, Frassica Simona, Ravaglione Federico, Villa Stefania, Alacqua Daniela, Martinelli Ottaviano, Villani Davide, Binaghi Emanuela, Caletti Matteo, Deriu Andrea, Vasile Gabriella, Ariaudo Giada, Morosini Paola, Salvatore Barbara, Breviglieri Maddalena, Capovilla Giuseppe, Galantini Chiara, Oldani Gaia, Valenti Vera, Battaini Chiara, Fornaro Emiddio, Valentino Alessandra, Vignoli Aglaia, Babboni Jessica, Bissoli Claudio, Costantino Antonella, Cropanese Isabella, Didoni Anna, Reale Laura, Canevini Maria Paola, Costantino Ilaria, Tessarollo Valentina, Walder Mauro, Baroffio Elisa, Borgatti Renato, Chiappedi Matteo, Capici Connie, Carpanelli Maria Luisa, Palmieri Maria Grazia, Ruffoni Gianpaolo, Mometti Sara, Rinaldi Francesco, Soardi Federica, Rossi Giorgio, Sgrò Carla, Termine Cristiano,
Abstract
AbstractAlthough the pharmacological therapy of ADHD has been widely studied, little has been done to compare the different therapeutic approaches (e.g., drug therapy vs. psychological treatments) and even less has been done to compare the outcome of the therapy between centers. This multicenter observational study aims to assess between-center variation in functional outcome of ADHD patients one year after the diagnosis, according to the treatment received. We used the Regional ADHD Registry data on 1429 patients enrolled in 16 ADHD centers in the 2011–2022 period. To evaluate the effectiveness of the therapy we used a generalized linear mixed model with the center as the random effect, including patient condition at diagnosis and center characteristics, weighting by the inverse of the propensity score of the treatment received by the patient. Between-center variation was expressed as the relative difference in odds-ratios between the observed and the expected number of patients whose condition improved, using the Clinical Global Impressions—Improvement Scale (CGI-I), and the relative 95% CI. Patients who received combined treatment were significantly more likely to improve compared to other treatment groups (65.5% vs 54.4% for methylphenidate alone, 53.4% for psychological treatment alone, or 40.5% for no therapy). Adjusted for patients and center characteristics, the log-odds ratio ranged from 0.85 (0.29–1.55 95% CI) to − 0.64 (− 1.17–− 0.18 95% CI). The mean expected probability of improvement after one year of therapy for an average patient with ADHD for each center was 47.7% in a center at the 25th percentile and 61.2% in a center at the 75th percentile of the outcome distribution after adjustments. The wide between-center variation in patient functional improvement one year after the diagnosis of ADHD could be largely explained by center-specific therapeutic approaches or attitudes. More careful and stringent work is needed to reduce differences in responses between centers, as could formal and periodic audit programs within and between centers.
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference41 articles.
1. Wolraich, M. L. et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528 (2019). 2. Faraone, S. V. et al. The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci. Biobehav. Rev. 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022 (2021). 3. Sayal, K., Prasad, V., Daley, D., Ford, T. & Coghill, D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatr. 5, 175–186. https://doi.org/10.1016/S2215-0366(17)30167-0 (2018). 4. Reale, L. & Bonati, M. ADHD prevalence estimates in Italian children and adolescents: a methodological issue. Ital. J. Pediatr. 44(1), 108. https://doi.org/10.1186/s13052-018-0545-2 (2018). 5. Baweja, R., Soutullo, C. A. & Waxmonsky, J. G. Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care. World J. Psychiatr. 11(12), 1206–1227. https://doi.org/10.5498/wjp.v11.i12.1206 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|